简介：The number of cases with end-stage liver disease coming to liver transplantation remains small. Although overall survival results are improving, management can be difficult with the potential interaction of immunosuppressive drugs, HAART, and the anti-viral therapy necessary to prevent recurrence of HCV/HBV.